For instance Sutton et al. (2017) reported 30.7% frequency of KRAS mutation in NSCLC on the basis of genotyping of 179 samples, majority of which were thin caliber needle cores with minimum tumor cellularity set at 20%. The gene discussed is KRAS; the disease is neoplasm.